Spark Biomedical, a Texas-based medical device company, announced that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal.
Opioid overdose deaths involving multiple substances among youth were found to be more common than overdose deaths involving only opioids, per the results of a study recently published by the Grayken Center at Boston Medical Center.
Johns Hopkins Medicine announced that it is collaborating with 14 other Maryland hospitals on a five-year initiative aimed at reducing the use of emergency departments and police for substance use and mental health crises.
Cognitive behavioral therapy was found to reduce symptoms of insomnia among young adult binge drinkers in a pilot study recently released by the University of Missouri School of Medicine and published in the Sleep Research Society journal.
Concerns over patient isolation, staff safety and licensing reciprocity between states as a means to address a shortage of care providers during a crisis were among the COVID-19-related topics discussed by a panel of industry leaders during a Friday morning session at the virtual National Conference on Addiction Disorders.
Fatal overdoses reported between January and April are up 11.4% compared to last year, and nonfatal overdoses are up 18.6%, with a spike that has coincided with the onset of the COVID-19 pandemic, according to data from ONDCP’s Overdose Data Mapping Application Program.
Jodi Maiolo, MPH, CPH, and Shanen Wright will discuss a campaign to reduce stigma in Appalachia that they worked on and how some of their takeaways can be used to create more effective messaging in other communities.